Chicago Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-295,878
Closed -$10M 53
2021
Q2
$10M Buy
+295,878
New +$7.54M 5.6% 7

Chicago Capital Management's CNST Position: Q3 2021 in Review

Chicago Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 295,878 shares — an estimated $10M sold.

Chicago Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $10M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Chicago Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Chicago Capital Management sold 295,878 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $10M.
  • Chicago Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Chicago Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $10M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Chicago Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.